2-18
Covaxin safe, well-tolerated in 2-18 years age-group, Bharat Biotech cites Lancet study-
admin
By Online Desk Bharat Biotech International Limited (BBIL) on Friday announced that its COVID-19 vaccine Covaxin has proven to be ...
SEC recommendations on Covaxin emergency use authorisation for 2-18 age group being examined: Government
admin
The CDSCO has also approved COVID-19 vaccine (ZyCoV-D) of Cadila Healthcare for restricted use in emergency situation in the age ...
